- XRP will now be used as a payment coin in pharmaceutical outlets in the US.
- The liberation of Ripple Labs from the US SEC lawsuit fuels the ecosystem’s growth.
Florida-based pharmaceutical distribution company Wellgistics is taking a new step by bringing XRP into its operations. Per the update, the health organization has secured a $50 million credit line to support payments and treasury management using XRP, the digital asset linked to Ripple Labs.
Healthcare Company Turns to XRP for Faster Payments
Wellgistics, a publicly listed healthcare infrastructure firm, plans to use XRP as a real-time payment tool and a reserve asset for its treasury.
According to a press release on May 8, the organization believes the digital currency will help cut costs and speed up cross-border transactions across the pharmaceutical supply chain.
Traditionally, wire transfers can take up to three days and incur high fees ranging from $10 to $30 per transaction. These methods also pose limitations regarding geography and transparency.
Wellgistics says it wants to eliminate those barriers by using XRP, which is known for its low fees and fast processing times. XRP transactions typically settle in 3 to 5 seconds and cost less than one cent.
This move puts Wellgistics among the first publicly traded healthcare firms to use XRP at this level. The company believes it will help pharmacies, suppliers, and manufacturers by speeding up payments and improving efficiency. It is also part of a larger plan to update how financial operations work in the medical field.
In line with Wellgistics’ announcement, we mentioned in our last update that a well-known analyst predicted great potential for XRP. He also revealed that several financial institutions are testing the asset for cross-border payments.
$50 Million Facility to Power Future Expansion
It is worth mentioning that to make this transition possible, Wellgistics has secured via a $50 million ELOC. This funding will support the implementation of XRP into its core operations, which is necessary for treasury reserves and daily payments.
The credit line will also allow the company to investigate other financial innovations. These include programmable liquidity options and on-demand payments, which could help Wellgistics offer more flexibility to its partners.
The decision reflects a growing shift in how industries, especially healthcare, use blockchain technology to improve their systems. With this development, Wellgistics signals that it adapts to change and prepares to lead in a space still primarily tied to traditional financial tools.
It is also important to mention that XRP has been in the news recently. For instance, as noted in our earlier post, an XRP enthusiast reacted to Ripple’s move to acquire Circle, the company behind the USDC stablecoin. They pointed out how this could affect XRP and its ecosystem.
Ripple seems focused on taking the lead in the payment space, gaining control of stablecoin systems, and pushing XRP as the go-to bridge currency.
Meanwhile, we recently covered that the US Securities and Exchange Commission (SEC) has settled with Ripple, reducing its earlier penalty from $125 million to $50 million. This settlement is a catalyst for the broader expansion within the Ripple ecosystem.
